#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prostate cancer Atypical haemolytic uraemic syndrome Neuroendocrine tumour of the lung Mantle cell lymphoma Retinal artery occlusion Haemolytic uraemic syndrome Deafness neurosensory Scleroderma associated digital ulcer Sexually transmitted disease Chronic granulomatous disease Hyperoxaluria Cardiac arrest Drug eruption Lung adenocarcinoma Inclusion body myositis More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma Crigler-Najjar syndrome – Treatment Familial haemophagocytic lymphohistiocytosis Hairy cell leukaemia recurrent – Basic Information Malignant fibrous histiocytoma – Treatment Mantle cell lymphoma stage IV – Treatment Mantle cell lymphoma stage IV – Life with Disease Idiopathic pulmonary fibrosis – Treatment Gastrointestinal stromal tumour – Trials in Disease Congenital generalised lipodystrophy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    HUPERZINE A Rbd1016 GSKVX000000034792 Cefazolin Sodium Lbl-007 Atrasentan Hydrochloride Ammonium Chloride Bp Gsk4004280 PRILOCAINE HYDROCHLORIDE Itepekimab Fludarabine Phosphate Ph. Eur. Enlicitide Chloride Minocycline Acou085 Canis Familiaris (553) Gefurulimab Emiplacel 13N-AMMONIA Ads-015 AZD0022 More therapies…

    Learn about Your Condition

    Peritoneal sarcoma Chronic lymphocytic leukaemia Metastases to rectum Immune thrombocytopenia Fatty acid oxidation disorder Colon cancer metastatic Impaired gastric emptying Endocarditis Vaginal cancer Dyspnoea Thermal burn Oesophagectomy Carotid artery occlusion Exudative retinopathy Rhabdomyosarcoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Retinal artery occlusion

  • Study comparing tenecteplase and acetylsalicylic acid in patients with central retinal artery occlusion within 4.

    Recruiting

    3 1 1
    Investigated Diseases:
    • Retinal artery occlusion
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Tenecteplase
    • Sodium Chloride
    Belgium Denmark Finland Ireland Norway Sweden

  • Study on Alteplase for Vision Recovery in Patients with Acute Central Retinal Artery Occlusion

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Retinal artery occlusion
    Investigated Drugs:
    • Tenecteplase
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!